3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
2
Uterine Prolapse
1
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity, Morbid
1
Menstruation Disturbances
1
Lung Neoplasms
1
Leiomyoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Genital Diseases, Female
1
Esophageal Neoplasms
1
Endometriosis
1
Adenomyosis
1
Interventions
asoprisnil
6
ulipristal acetate
3
Hysterectomy
2
relugolix
1
cetrorelix
1
Videotape Recording
1
Uterine Artery Embolization
1
Triptorelin Pamoate
1
Tablets
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Salpingectomy
1
Rocuronium
1
Robotic Surgical Procedures
1
Restraint, Physical
1
Naproxen
1
Mifepristone
1
Menotropins
1
Leuprolide
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
High-Energy Shock Waves
1
Gonadotropins
1
Electrocoagulation
1
Chorionic Gonadotropin
1
Bupivacaine
1
Anesthesia, General
1
Analgesia, Patient-Controlled
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leiomyoma
×
Robotic Surgical Procedures
×
Gynecologic
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled